Breast hyperplasia
Conditions
Interventions
experimental group:ShuRUXiaoJie granules,1 packet, twice daily
control subjects:Xiaojin Pills, 1.5g, twice daily
Sponsors
Lanzhou Second People's Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: According to the relevant provisions of ZY/T001.2-94 issued by the State Administration of Traditional Chinese Medicine (SATCM) on the Diagnostic and Therapeutic Efficacy Standards of Chinese Medicine, and according to the Chinese Medical Surgery Society of China's Breast Disease Specialized Committee's eighth meeting, which passed the "Chinese Medicine Dialectical Typing Standards of Breast Hyperplasia", breast hyperplasia was classified into: liver-depressing and qi stagnation, phlegm and stasis interlacing, and Chong Ren disorders, for females aged =18 years old;
Exclusion criteria
Exclusion criteria: Patients with pregnancy, lactation, severe menstrual cycle disorders, functional uterine bleeding, breast malignancy and inflammatory diseases, and patients with other diseases treated with immunotherapy or hormone therapy. Any other cancer or history of cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Numeric Score;Chinese Medicine Symptom Score;Ductal width of the breast;Diameter of breast mass;Breast Gland Thickness;Structural ratings of breast enlargement; | — |
Secondary
| Measure | Time frame |
|---|---|
| anxiety index;estrogen level;progesterone level;Follicle stimulating hormone levels;Breast hypoechoic diameter; | — |
Countries
China
Contacts
Public ContactYu Bo; Biaofeng SHAN
Lanzhou Second People's Hospital
Outcome results
None listed